We have a great selection of live and on-demand webcasts available. If there are topics you'd like to see us cover, please let us know.
When: March 26th, 2014 @ 11:30am ET
Tune in to our webcast to learn how sponsors and CROs are tackling the challenge of developing a comprehensive drug development strategy. Learn how issues such as slow study enrollment, trial designs that do not meet regulatory expectations, or prohibitively expensive raw materials can be more easily managed or avoided altogether if development starts with a comprehensive strategy.
Listen to this webcast to learn how sponsors and CROs are tackling recruitment challenges by trending towards a greater use of technology, web-based tools, social and mobile media, and a global net for site selection.
Clinical trial participation rates are especially low among adult minorities and underserved populations in spite of their bearing a disproportionate burden of disease. The gap in representative enrollment limits the knowledge base for determining the effectiveness and safety of strategies for treating cancer. Tune in to our webcast to learn how to overcome these challenges!
Despite its rich pipeline, cardiovascular device innovation is declining. Both the cost and development time required to bring devices to market have increased in recent years. Tune in to our webcast to learn more about the cardiovascular device research pipeline and approval trends.
Current EU legislation on medical devices is outdated (some directives are more than 20 years old) and often inconsistently interpreted by member states. Learn about the challenges facing EU nations with the modernization and expansion of medical device regulations and how...
An estimated 3% of US adult cancer patients participate in clinical trials. The low participation rate is a major bottleneck in developing new cancer treatments. A key factor in progress toward better treatment and prognosis in adult oncology lies in improving participation rates.
Learn more about the emerging changes to the standard interpretation of laws governing the import of clinical trial supplies into the US and to explore best practices for overcoming this latest hurdle.
Digital CROs set themselves apart from traditional CROs by leveraging innovative, technology-amplified tools and processes to deliver more efficient and effective clinical trial management services. Join our panel of experts for an interactive presentation on this technology-amplified approach to clinical trial management.
On-site monitoring accounts for up to 30% of your study costs. It’s in your best interest to work with a CRO using the best, most efficient methods for study oversight and quality assurance. Join our panel of experts for an interactive discussion to learn how the use of a technology-amplified, real-time, risk-based approach to monitoring can help.
With pressure on global pharma and biotech companies to bring products to market faster while also cutting costs, many have turned their focus to streamlining study start-ups. While some factors are outside of a sponsor’s direct control, there are strategies sponsors can implement to positively impact start-up timelines.